Aquatic Capital Management’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
Other funds holding AMED
DM
RP
AAM
Aquatic Capital Management's AMED Position: Q2 2023 in Review
Aquatic Capital Management sold out of Amedisys (AMED) in Q2 2023, closing a stake of 8,700 shares — an estimated $640K sold.
Aquatic Capital Management first reported a position in AMED in Q1 2022 and held it in 5 quarters. The position peaked at $1.53M in Q3 2022. 301 funds tracked by Wall St. Rank hold AMED as of Q2 2023.
- Aquatic Capital Management reported no remaining Amedisys position as of Q2 2023 after selling out during the quarter.
- Aquatic Capital Management sold 8,700 Amedisys shares in Q2 2023, an estimated $640K.
- Aquatic Capital Management first reported a position in Amedisys in Q1 2022 and held it in 5 quarters.
- Aquatic Capital Management's Amedisys position peaked at $1.53M in Q3 2022.
- 301 funds tracked by Wall St. Rank held Amedisys as of Q2 2023.
Based on Aquatic Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.